Precision oncology accelerates development and improves results
At Novartis Oncology, we are a leader in driving the practice of precision oncology treatment. Precision oncology is the evolving understanding of how cancers develop on a genomic level and our ability to develop drugs that hone in on those targets – ultimately leading to better patient outcomes.
Our research is driven by a distinctive scientific and clinical strategy, focusing on unmet medical needs and disease pathways:
- Identify pathways where cancers most commonly occur
- Screen compounds to identify ones with greatest potential to impact pathway
- Identify biomarkers and create diagnostic tools
- Target patients most likely to benefit from therapy
Thanks to this approach, the Novartis Oncology Pipeline is one of the strongest and most productive pipelines in the industry.